Total Payments
$1,316
2024 Payments
$97.48
Companies
12
Transactions
62
Medicare Patients
476
Medicare Billing
$58,067
Payment Breakdown by Category
Food & Beverage$1,316 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,316 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $254.75 | 12 | $0 (2023) |
| Alkermes, Inc. | $175.63 | 4 | $0 (2021) |
| ABBVIE INC. | $171.19 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $167.06 | 8 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $129.84 | 2 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $120.03 | 7 | $0 (2022) |
| Eisai Inc. | $108.02 | 7 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $57.37 | 3 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $44.00 | 3 | $0 (2021) |
| ITI, Inc. | $35.71 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97.48 | 5 | Janssen Pharmaceuticals, Inc ($47.67) |
| 2023 | $50.23 | 3 | Otsuka America Pharmaceutical, Inc. ($36.70) |
| 2022 | $200.42 | 10 | ABBVIE INC. ($87.00) |
| 2021 | $494.79 | 22 | Alkermes, Inc. ($125.00) |
| 2020 | $369.80 | 21 | Otsuka America Pharmaceutical, Inc. ($91.62) |
| 2019 | $103.62 | 1 | Alexion Pharmaceuticals, Inc. ($103.62) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Neuroscience | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Neurology | ||||||
| 01/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 01/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Neurology | ||||||
| 11/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PSYCHIATRY | ||||||
| 04/27/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $45.97 | General |
| Category: Neuroscience | ||||||
| 09/20/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Neuroscience | ||||||
| 07/08/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Neuroscience | ||||||
| 06/21/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Neuropsychiatry | ||||||
| 12/22/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/14/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 11/19/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/18/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROLOGY | ||||||
| 11/02/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $75.98 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Neuroscience | ||||||
| 08/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 283 | 471 | $95,632 | $34,028 |
| 2022 | 5 | 151 | 297 | $54,152 | $20,764 |
| 2021 | 2 | 42 | 82 | $6,614 | $3,275 |
Total Patients
476
Total Services
850
Medicare Billing
$58,067
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 87 | 228 | $35,763 | $13,449 | 37.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 76 | 86 | $30,196 | $10,106 | 33.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 34 | 41 | $9,790 | $3,504 | 35.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 29 | $8,580 | $2,763 | 32.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 54 | $5,098 | $1,972 | 38.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Office | 2023 | 14 | 14 | $3,640 | $1,332 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Office | 2023 | 18 | 19 | $2,565 | $902.04 | 35.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 192 | $25,756 | $10,097 | 39.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 32 | 38 | $13,252 | $4,969 | 37.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $4,906 | $1,926 | 39.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 21 | $4,158 | $1,644 | 39.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 13 | $3,380 | $1,095 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Office | 2022 | 20 | 20 | $2,700 | $1,034 | 38.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 37 | $4,121 | $1,982 | 48.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 20 | 45 | $2,493 | $1,292 | 51.8% |
About Dr. Brittany Richardson, DO
Dr. Brittany Richardson, DO is a Psychiatry healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1134626583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brittany Richardson, DO has received a total of $1,316 in payments from pharmaceutical and medical device companies, with $97.48 received in 2024. These payments were reported across 62 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,316).
As a Medicare-enrolled provider, Richardson has provided services to 476 Medicare beneficiaries, totaling 850 services with total Medicare billing of $58,067. Data is available for 3 years (2021–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Emotionally Disturbed Children|Psychiatry
- Location Ashland, KY
- Active Since 04/11/2018
- Last Updated 07/07/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134626583
Products in Payments
- ABILIFY MAINTENA (Drug) $181.81
- VRAYLAR (Drug) $171.19
- LYBALVI (Drug) $125.00
- INGREZZA (Drug) $120.03
- SPRAVATO (Drug) $115.30
- Dayvigo (Drug) $108.02
- KAPSPARGO (Drug) $57.37
- REXULTI (Drug) $54.81
- INVEGA SUSTENNA (Drug) $51.76
- ARISTADA (Drug) $50.63
- CAPLYTA (Drug) $35.71
- UZEDY (Drug) $33.17
- HETLIOZ (Drug) $28.17
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $19.57
- ABILIFY ASIMTUFII (Drug) $18.13
- FANAPT (Drug) $15.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Ashland
Scott Lance, M.d, M.D
Psychiatry — Payments: $10,543
Psychiatry $10,543
Dr. Manish Parikh, Md, MD
Psychiatry — Payments: $5,205
Psychiatry $5,205
Frances Swarn, M.d, M.D
Psychiatry — Payments: $2,592
Psychiatry $2,592
Anne Zappacosta, Md, MD
Psychiatry — Payments: $1,784
Psychiatry $1,784
Amber Wireman, Do, DO
Psychiatry — Payments: $1,193
Psychiatry $1,193
Veronika Logovinsky, M.d, M.D
Psychiatry — Payments: $880.92
Psychiatry $880.92